Jove
Visualize
Contact Us

Related Experiment Videos

Viral hepatitis A, B, and C.

A Regev1, E R Schiff

  • 1Center for Liver Diseases, Jackson Medical Towers, Suite 1101, 1500NW 12th Avenue, Miami, Florida, 33136 USA.

Clinics in Liver Disease
|March 10, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A self-adaptive hardware with resistive switching synapses for experience-based neurocomputing.

Nature communications·2023
Same author

SM-Omics is an automated platform for high-throughput spatial multi-omics.

Nature communications·2022
Same author

Application of ventricular tachyarrhythmia definitions of the updated Lambeth Conventions provides incompatibility with earlier results, masks antifibrillatory activity and reduces inter-observer agreement.

Journal of physiology and pharmacology : an official journal of the Polish Physiological Society·2019
Same author

Rare coding variant analysis in a large cohort of Ashkenazi Jewish families with inflammatory bowel disease.

Human genetics·2018
Same author

Pharmacodynamic comparison of LY3023703, a novel microsomal prostaglandin e synthase 1 inhibitor, with celecoxib.

Clinical pharmacology and therapeutics·2015
Same author

Clonal expansion of hepatocytes with a selective advantage occurs during all stages of chronic hepatitis B virus infection.

Journal of viral hepatitis·2015
Same journal

Metabolic Dysfunction-Associated Steatohepatitis: From Fibrosis-Based Risk Stratification to Emerging Therapeutic Strategies.

Clinics in liver disease·2026
Same journal

Metabolic Dysfunction-Associated Steatotic Liver Disease and Viral Hepatitis.

Clinics in liver disease·2026
Same journal

Metabolic Dysfunction Associated Steatohepatitis (MASH) in Oceania, Central America, and the Caribbean.

Clinics in liver disease·2026
Same journal

Metabolic Dysfunction-Associated Steatotic Liver Disease in Latin America.

Clinics in liver disease·2026
Same journal

Metabolic Dysfunction-Associated Steatotic Liver Disease in Africa: From Burden to Action.

Clinics in liver disease·2026
Same journal

Metabolic Dysfunction-Associated Steatotic Liver Disease in Asia: Epidemiology, Clinical Features, and Management.

Clinics in liver disease·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Significant advancements in understanding viral hepatitis (Hepatitis A, B, and C) occurred in the 20th century. Key developments include identifying viruses, diagnostic markers, vaccines, and antiviral therapies for these infectious diseases.

Area of Science:

  • Hepatology
  • Virology
  • Infectious Diseases

Background:

  • Viral hepatitis has been known for centuries, but significant progress in understanding Hepatitis A, B, and C occurred in the latter half of the 20th century.
  • This period saw the confirmation of the infectious nature of these viruses, leading to their identification and characterization.

Purpose of the Study:

  • To review major advancements in the understanding and management of viral hepatitis A, B, and C during the 20th century.

Main Methods:

  • Review of epidemiological studies to understand transmission and prevention.
  • Application of molecular biology and cell culture techniques to study viral genomes.
  • Development and implementation of serologic markers for diagnosis.

Related Experiment Videos

Main Results:

  • Identification and description of Hepatitis A, B, and C viruses.
  • Establishment of serologic markers for accurate diagnosis.
  • Development of vaccines for Hepatitis A and B, and effective antiviral therapies for chronic Hepatitis B and C.

Conclusions:

  • The 20th century witnessed transformative progress in viral hepatitis research, diagnostics, prevention, and treatment.
  • Continued research in molecular biology and antiviral therapies holds promise for managing chronic viral hepatitis.